Oscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow OSCR
Oscar Health, Inc. (OSCR) P/E ratio
As of 13 October 2026, Oscar Health, Inc. (OSCR) trades at a P/E ratio of 19.8×. Over the past ten years it has ranged from 0.0× (June 2026) to 388× (September 2024); the current reading is higher than 82% of that period. That is below the Healthcare Plans industry median of 23.6× and below the Healthcare sector median of 22.8×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 79.1× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 16.7× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 22 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CNC Centene Corporation compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CLOV Clover Health Investments, Corp. compare | n/m |
| CI Cigna Group compare | 11.7× |
| ELV Elevance Health, Inc. compare | 18.8× |
| OSCR Oscar Health, Inc. | 19.8× |
| PGNY Progyny, Inc. compare | 28.2× |
| HUM Humana Inc. compare | 39.5× |
| ALHC Alignment Healthcare, Inc. compare | 39.5× |
| Healthcare Plans industry median | 23.6× |
| Healthcare sector median | 22.8× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)